Research helps scientists and doctors better understand health and disease, leading to new ways to prevent, diagnose, and treat illnesses. By participating in a clinical trial, you can play a vital role in advancing discoveries that may improve health outcomes for everyone.Read More…

Scientists at The Institute of Cancer Research, London, are calling for targeted screening after finding that PSA testing picked up more dangerous prostate cancers in men with BRCA1 and BRCA2 mutations than non-carriers.Read More…

Men and women with mutations in either the BRCA1 or BRCA2 gene are at an increased risk of developing certain cancers, including breast, ovarian, pancreatic, or prostate.Read More…

Funded research includes grants to U.S. and international academic institutions: projects include research, screening, treatment, and outreach efforts for men with BRCA genetic mutations.Read More…

Drs. Kara Maxwell, Daniel Lee, Jennifer Zhang and Bryson Katona review the nuances of BRCA+ breast, prostate, and pancreatic cancers in men.Read More…

CureBRCA is partnering with the Ann & Robert H. Lurie Children’s Hospital of Chicago in support of the Polsky Family Genetic Testing Initiative. This collaboration will expand access to vital genetic testing for patients and families, with an estimated 275 individuals benefiting through the Cancer Predisposition Program in Lurie Children’s Center for Cancer and Blood Disorders.Read More…

CureBRCA will consider funding BRCA-related initiatives that involve prevention, detection, screening, and/or treatment for men at risk for BRCA-related cancers. Applications are due by March 15, 2025.Read More…

The BRCA Research & Cure Alliance (CureBRCA) will be launching its 2025 Research Awards Program soon. Full information regarding types of applications being sought, eligibility, funding details, evaluation process, and the online application process will be posted here on November 1, 2024.Read More…

Published by: JAMA Oncology

This peer-reviewed article’s lead author is Heather Cheng, MD, PhD, with key contributions from Kara Maxwell, MD, PhD, Bryson Katona, MD, PhD, and Jeffrey Shevach, MD, along with a distinguished team of international experts.Read More…